IMPACT: Interim Physical Activity Intervention Results for Pediatric Cancer Patients

Interim results from the IMPACT trial, a 12-week supervised physical activity intervention delivered via videoconference for pediatric cancer patients. The data covers 93 patient referrals and 12 intervention completions between March 2022 and December 2024, analyzing implementation metrics and secondary effectiveness outcomes. The dataset was authored by Emma McLaughlin and shared under a CC-BY-4.0 license.

Use Cases

• Analyzing implementation fidelity based on reported 95.2% session adherence rate.
• Studying recruitment and retention challenges based on 39% participation and 33% trial retention rates.
• Evaluating intervention safety based on the reported absence of adverse events.
• Assessing changes in patient-reported quality of life based on pre- and post-intervention PedsQL scores.

Strengths

• Includes detailed interim metrics on reach, adoption, and implementation for 93 referred patients.
• Reports high intervention delivery fidelity of 95.2% ± 3.83%.
• Covers over 300 hours of accrued intervention and trial delivery time.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is small (887.4 KB), representing interim results from a limited sample of 14 enrolled participants.

Provenance

Source

Emma McLaughlin via figshare

Collection Method

Data collected from a hybrid effectiveness-implementation trial of the IMPACT physical activity intervention.

Time Range

March 2022 to December 2024

Freshness

Last updated 2026-03-17 13:09:25